Improved efficacy of taxanes and ramucirumab combination chemotherapy after exposure to anti-PD-1 therapy in advanced gastric cancer

BACKGROUND: The efficacy and safety of chemotherapy (CTx) after anti-PD-1 therapy in patients with advanced gastric cancer (AGC) remains unclear. METHODS: Medical records of consecutive patients with AGC treated with both CTx (taxanes plus ramucirumab, taxanes monotherapy or irinotecan) and anti-PD-...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki, Akinori, Kawazoe, Akihito, Eto, Testuya, Okunaka, Mashiro, Mishima, Saori, Sawada, Kentaro, Nakamura, Yoshiaki, Kotani, Daisuke, Kuboki, Yasutoshi, Taniguchi, Hiroya, Kojima, Takashi, Doi, Toshihiko, Yoshino, Takayuki, Akimoto, Tetsuo, Shitara, Kohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381840/
https://www.ncbi.nlm.nih.gov/pubmed/32719002
http://dx.doi.org/10.1136/esmoopen-2020-000775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381840/
https://www.ncbi.nlm.nih.gov/pubmed/32719002
http://dx.doi.org/10.1136/esmoopen-2020-000775

Ejemplares similares